The past two years have been a season of resets. Bankruptcies, closures and pivots captured the headlines, but another equally important story has been consolidation. While the word can feel like a euphemism for weakness, the reality is more nuanced.

Zinzino announced it has officially completed the acquisition of Truvy. With the acquisition of rights to Truvy’s distributor database and associated customer registry, inventory and IP rights, as well as 100% of shares in Truvy’s South Korean subsidiary, Zinzino has increased its distribution capacity in North America, Latin America and South Korea.

Zinzino acquired the rights to the distributor database and associated customer register, inventory, and IP rights of the US-based direct sales company Bodē Pro through an asset acquisition. 

Zinzino AB announced plans to acquire direct sales company Truvy. The asset acquisition will include Truvy’s distributor database, associated customer register, inventory and IP rights.

Zinzino released its preliminary sales report for July 2025. Revenue in July for Zinzino’s sales markets increased by 64% year-over-year, while Faun Pharma’s external sales showed decline. Overall, the group experienced a 55% revenue increase year-over-year.

Zinzino announced its preliminary Q2 2025 earnings report. Group revenue during the quarter rose 56% year-over-year, reaching $83 million.

Zinzino announced it has acquired the rights to Ecosystem’s inventory, IP and distributor database and associated customer records. Ecosystem’s presence in France and headquarters in Paris is expected to generate strong growth for Zinzino within the French market.

Direct Approach, the official podcast of Direct Selling News, is excited to announce that Episode 106, “From Skeptic to CEO: Ørjan Sæle’s Disruptive Path to Reinventing Direct Sales,” has reached 6,000 unique views within its first 30 days, making it one of the fastest-growing episodes in the show’s history.

Zinzino announced a market launch into China with a cross-border social e-commerce model as the next step in its strategic expansion.

Over the last 20 years, Ørjan and Hilde Sæle have turned Zinzino from a small, Scandinavian coffee startup into an international life science pioneer of test-based, personalized nutrition. What began as a response to past frustrations has grown into a mission to redefine health focused on prevention and precision, positioning the Norwegian husband-and-wife team as global leaders who don’t just see the future—they build it.

In its April 2025 sales report, Zinzino announced a significant positive revenue trend. Group revenue for the company increased 54% in April compared to the same month in 2024 and reached $26 million.

Zinzino announced it has acquired the rights to Valentus Global’s distributor database and associated customer records, inventory and IP rights via an asset purchase. Though based in Delaware, much of Valentus’ operations and sales take place within European markets, and Zinzino expects the acquisition will bolster its distribution power across the region.